Effectiveness and safety of tocilizumab therapy for patients with rheumatoid arthritis and renal insufficiency: a real-life registry study in Japan (the ACTRA-RI study)

Detalles Bibliográficos
Autores principales: Mori, Shunsuke, Yoshitama, Tamami, Hidaka, Toshihiko, Hirakata, Naoyuki, Ueki, Yukitaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2015
Materias:
Letters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4345886/
https://www.ncbi.nlm.nih.gov/pubmed/25561361
http://dx.doi.org/10.1136/annrheumdis-2014-206695
_version_ 1782359646707646464
author Mori, Shunsuke
Yoshitama, Tamami
Hidaka, Toshihiko
Hirakata, Naoyuki
Ueki, Yukitaka
author_facet Mori, Shunsuke
Yoshitama, Tamami
Hidaka, Toshihiko
Hirakata, Naoyuki
Ueki, Yukitaka
author_sort Mori, Shunsuke
collection PubMed
description
format Online
Article
Text
id pubmed-4345886
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-43458862015-03-18 Effectiveness and safety of tocilizumab therapy for patients with rheumatoid arthritis and renal insufficiency: a real-life registry study in Japan (the ACTRA-RI study) Mori, Shunsuke Yoshitama, Tamami Hidaka, Toshihiko Hirakata, Naoyuki Ueki, Yukitaka Ann Rheum Dis Letters BMJ Publishing Group 2015-03 2015-01-05 /pmc/articles/PMC4345886/ /pubmed/25561361 http://dx.doi.org/10.1136/annrheumdis-2014-206695 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
spellingShingle Letters
Mori, Shunsuke
Yoshitama, Tamami
Hidaka, Toshihiko
Hirakata, Naoyuki
Ueki, Yukitaka
Effectiveness and safety of tocilizumab therapy for patients with rheumatoid arthritis and renal insufficiency: a real-life registry study in Japan (the ACTRA-RI study)
title Effectiveness and safety of tocilizumab therapy for patients with rheumatoid arthritis and renal insufficiency: a real-life registry study in Japan (the ACTRA-RI study)
title_full Effectiveness and safety of tocilizumab therapy for patients with rheumatoid arthritis and renal insufficiency: a real-life registry study in Japan (the ACTRA-RI study)
title_fullStr Effectiveness and safety of tocilizumab therapy for patients with rheumatoid arthritis and renal insufficiency: a real-life registry study in Japan (the ACTRA-RI study)
title_full_unstemmed Effectiveness and safety of tocilizumab therapy for patients with rheumatoid arthritis and renal insufficiency: a real-life registry study in Japan (the ACTRA-RI study)
title_short Effectiveness and safety of tocilizumab therapy for patients with rheumatoid arthritis and renal insufficiency: a real-life registry study in Japan (the ACTRA-RI study)
title_sort effectiveness and safety of tocilizumab therapy for patients with rheumatoid arthritis and renal insufficiency: a real-life registry study in japan (the actra-ri study)
topic Letters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4345886/
https://www.ncbi.nlm.nih.gov/pubmed/25561361
http://dx.doi.org/10.1136/annrheumdis-2014-206695
work_keys_str_mv AT morishunsuke effectivenessandsafetyoftocilizumabtherapyforpatientswithrheumatoidarthritisandrenalinsufficiencyarealliferegistrystudyinjapantheactraristudy
AT yoshitamatamami effectivenessandsafetyoftocilizumabtherapyforpatientswithrheumatoidarthritisandrenalinsufficiencyarealliferegistrystudyinjapantheactraristudy
AT hidakatoshihiko effectivenessandsafetyoftocilizumabtherapyforpatientswithrheumatoidarthritisandrenalinsufficiencyarealliferegistrystudyinjapantheactraristudy
AT hirakatanaoyuki effectivenessandsafetyoftocilizumabtherapyforpatientswithrheumatoidarthritisandrenalinsufficiencyarealliferegistrystudyinjapantheactraristudy
AT uekiyukitaka effectivenessandsafetyoftocilizumabtherapyforpatientswithrheumatoidarthritisandrenalinsufficiencyarealliferegistrystudyinjapantheactraristudy

Ejemplares similares